|
media relations
| | | |
| | |
|
TransMolecular Reports Positive Phase
2 Data from Study of  Iodine
Radiolabeled TM-601 in Recurrent Glioma
read
more 
Study Demonstrates Safety of Promising
New Treatment for glioblastoma; Deadly Brain Cancer
read
more
Synthetic Version of Scorpion Venom
Delivers Radioactive Iodine to Malignant Brain Tumors
read
more
To access all press releases, click
here.
TransMolecular, Inc. invites scientific reporters
and editors to contact us with questions or requests for additional
information. Interested parties can direct inquiries and requests
to:
Debbie Harris
TransMolecular, Inc.
840 Memorial Drive, Second Floor
Cambridge, MA 02139
Phone: (205) 250-6392
Fax: (205) 250-6399
Email: harris@transmolecular.com
If would like to receive the most current
breaking news and press releases from TransMolecular, Inc., please
send us your name, company name and email address to: info@transmolecular.com
|
